ArticleActive
Response to Comments: MolDX: HLA-DQB1*06:02 Testing for Narcolepsy (DL37003).
A55536
Wisconsin Physicians Service Insurance Corporation (J05)
Effective: July 17, 2017
Updated: December 31, 2025
Policy Summary
This article (A55536) summarizes comments received on Draft LCD DL37003 regarding MolDX HLA-DQB1*06:02 testing for narcolepsy and does not itself state coverage indications, exclusions, documentation requirements, or frequency limits. For actionable coverage criteria refer to the underlying LCD DL37003; manual review is recommended.
Coverage Criteria Preview
Key requirements from the full policy
"No documentation requirements for coverage are specified in this article; the document only summarizes comments received on Draft LCD DL37003 (MolDX: HLA-DQB1*06:02 testing for narcolepsy)."
Sign up to see full coverage criteria, indications, and limitations.